Abingworth Bioventures 8 closes on $465m
Abingworth has held a final close for its new life sciences fund, Abingworth Bioventures 8 (ABV 8), on its $465m hard-cap, exceeding its $375m target.
Abingworth has held a final close for its new life sciences fund, Abingworth Bioventures 8 (ABV 8), on its $465m hard-cap, exceeding its $375m target.
Used-car trading platform Auto1, which is backed by VCs including Softbank and Target Global, has announced it has set its final offer price at €38 per share ahead of its IPO on the Frankfurt Stock
The European VC market has quietly kept on building a head of steam in the past 12 months, regardless of a pandemic that otherwise threatened to cripple entire sections of the private equity industry, Unquote
The operations divested from the Japanese business include Shiseido’s well-known drugstore brands, such as Tsubaki hair care products and Senka face wash
Biotech investment specialist Arch Venture Partners has hit a $1.85bn final close for its eleventh flagship fundraise, less than a year after hauling in almost $1.5bn for its predecessor vehicle.
CVC Capital Partners has invested in the International Volleyball Federation (Fédération Internationale de Volleyball, FIVB), the Switzerland-headquartered governing body of volleyball.
Israel-based venture capital house FinTLV has raised $120m for its second fund targeting global growth-stage insurtech and fintech companies.
Siena Venture Partners is aiming to close a €25m fund for late-stage venture capital investments by the end of 2021, partner Lauri Isotamm has told Unquote.
